Navigation Links
First Patient Treated in U.S.-Approved Embryonic Stem Cell Trial
Date:10/12/2010

By Amanda Gardner
HealthDay Reporter

MONDAY, Oct. 11 (HealthDay News) -- The first patient to be treated in a U.S.-government-approved study involving human embryonic stem cells has been injected with millions of the potentially life saving cells.

The patient, being cared for at the Shepherd Center in Atlanta, is partially paralyzed following a spinal cord injury. The center specializes in treating these types of injuries.

According to the trial's protocol, patients must receive the stem cell injection within 14 days of the injury. The trial only involves patients with spinal cord injuries.

"We've known about this for a long time, we've been waiting for it to happen and we hope it goes well. Definitely it's a step forward," said Susan L. Solomon, CEO of the New York Stem Cell Foundation.

Paul Sanberg, professor of neurosurgery and director of the
 University of South Florida Center for Aging and Brain Repair in Tampa, added: "Clearly this bodes well, in the sense of getting stem cells to the clinic, especially in spinal cord injury. This is a safety study, and once that continues, hopefully there will be good efficacy."

While many scientists and physicians are hailing the trial as a landmark, others have expressed some nervousness.

"There's a lot of angst around these trials," Evan Y. Snyder, director of the stem cell program at the Sanford-Burnham Medical Research Institute in San Diego, told the Washington Post. "There's going to be this perception that if the cells do not perform well, the entire field will be illegitimate."

Spinal cord injuries are just one of several conditions and diseases that scientists hope can one day be treated, cured or prevented with stem cell therapy. Others include Alzheimer's disease, Parkinson's and diabetes.

Although researchers around the world have made strides in the field, until now, no clinical trials have gotten under way in the United States.

The current Phase I trial, sponsored by Geron Corp. of Menlo Park, Calif., is mainly looking at the safety of using embryonic stem cells in this context. If all goes well, later trials will assess the strategy's effectiveness.

In an announcement released Monday, Geron president and CEO Dr. Thomas B. Okarma said that "initiating [this] clinical trial is a milestone for the field of human embryonic stem cell-based therapies."

According to the company statement, another center, Northwestern Medicine in Chicago, is also enrolling patients for a similar trial.

In all, seven sites will be involved in the study, the Post reported.

Embryonic stem cell therapy has been a major source of controversy and political drama for years. Early in President George W. Bush's first term, his administration banned federal funding for research using newly created embryonic stem cells, citing ethical concerns that these cells represented viable human life.

That ban was overturned by the Obama administration, but in late August U.S. District Court Judge Royce Lamberth ruled that federal funding of embryonic stem cell research did violate a 1996 law prohibiting the use of taxpayer dollars for such work. The Obama administration appealed that decision.

Soon after, an appeals court issued a temporary suspension of the reinstituted ban until it could hear full arguments over the next few weeks.

In the wake of that stay, U.S. government officials announced that researchers at the National Institutes of Health would resume working with embryonic stem cells.

Meanwhile, results of a new Harris Interactive/HealthDay poll released last week found that a wide range of Americans, including Republicans, Catholics and born-again Christians, supported embryonic stem cell research. Almost three-quarters (72 percent) of the adults surveyed believe that scientists should be allowed to use embryonic stem cells left over from in vitro fertilization procedures to search for potential treatments or ways to prevent diseases such as Parkinson's, Alzheimer's and diabetes.

More information

Find out more about stem cell research at the U.S. National Institutes of Health.

SOURCES: Susan L. Solomon, CEO, New York Stem Cell Foundation, New York City; Paul Sanberg, Ph.D., D.Sc., professor of neurosurgery, and director of the University of South Florida Center for Aging and Brain Repair, Tampa; Oct. 11, and Aug. 29, 2010, Washington Post; Oct. 11, 2010, Geron Corp. news release


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program
2. Retired Military Brass Support First Ladys Call to Reduce Child Obesity, Improve Nutrition
3. NASBE Supports First Lady Michelle Obama in Fight Against Childhood Obesity
4. PolicyLink CEO Angela Glover Blackwell Released the Following Statement on First Lady Michelle Obamas Childhood Obesity Initiative
5. MSU launches first anti-counterfeiting research program
6. AMA Joins First Lady in Fight Against Childhood Obesity
7. National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal
8. First blinded study of venous insufficiency prevalence in MS shows promising results
9. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
10. First Gene Variants Linked to Stuttering Discovered
11. FAB-HOMES™ Presents First Passive House Collection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First Patient Treated in U.S.-Approved Embryonic Stem Cell Trial 
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today announces distribution ... the current obstacles facing infection prevention and offer strategies for the health care ... infections. , The print component of “Fighting Infection” is distributed within the ...
(Date:3/24/2017)... ... , ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce the ... clinic is the group’s 7th location in San Antonio and 23rd in Texas. ... care from the clinic, which opened March 22, 2017. , The team ...
(Date:3/24/2017)... ... 2017 , ... As the standards bearer of advanced cancer ... positions them as the go-to thought leader in all matters concerning oncology nursing. ... always-on, always-fresh news, views and advocacy engine, called ONS Voice. , The ONS ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ... prep patients for colonoscopy at the HyGIeaCare® Center that is to be located ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of Christian ... Bible teacher residing in North Carolina with his wife, Anna Marie. He and his ... six grandchildren. David is also the author of “Shadow and Substance.” , “Love, the ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... FinancialBuzz.com News Commentary   ... cannabis products around the world are projected to gain popularity. A report ... will reach a value of USD 55.8 billion by 2025. ... industry. By the end of 2016, 28 states have now laws and ... states like Arkansas and North Dakota ...
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com report ... been growing rapidly as the global sales of Adcetris and Kadcyla ... in the antibody drug conjugates market is driven by large number ... and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for ... Europe , Asia-Pacific , ... are provided for the period 2015 through 2022. Also, a six-year historic ...
Breaking Medicine Technology: